Medical News

RSS

The protective effects of extra virgin olive oil on disease risk factors

Researchers conducted a systematic review to consolidate recent evidence on the preventive benefits of extra virgin olive oil on disease risk factors.

29 Jun 2023

Tirzepatide triumphs in significant weight reduction for people with type 2 diabetes

Researchers performed a double-blinded, placebo-controlled phase III randomized clinical trial (RCT).

29 Jun 2023

Researchers screen 16 UK native bat species for coronaviruses with zoonotic potential

A recent study published in Nature Communications screened for coronaviruses in 16 native species of bats in the UK.

29 Jun 2023

The Lancet study unveils exciting findings on retatrutide as a novel treatment for type 2 diabetes

Researchers performed a phase II randomized clinical trial (RCT).

29 Jun 2023

From deserts to desserts: cacti components for new functional foods

Researchers described promising features of using cactus in the food sector, addressing the plant's functional, nutritional, and sustainable qualities.

29 Jun 2023

Study reveals oral Semaglutide 50 mg as promising treatment for obesity in adults: the Lancet report

Researchers performed a phase III randomized clinical trial (RCT).

29 Jun 2023

Study suggests blood group A may directly influence SARS-CoV-2 infectious risk

Researchers evaluated the association between blood group A and SARS-CoV-2 infections.

29 Jun 2023

Understanding the biological effects of SARS-CoV-2 persistence in children

Researchers analyzed the most recent knowledge about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

29 Jun 2023

Albumedix enters into collaboration agreement with Cell and Gene Therapy Catapult

Albumedix Ltd., an enabler of advanced therapies and the world leader in recombinant human albumin (rAlb), announced today that they have entered into a collaboration agreement with Cell and Gene Therapy Catapult (CGT Catapult) to investigate the use of Albumedix´ proprietary albumin-based solutions for advanced therapy applications, including viral vectors manufacturing.

From Albumedix Ltd. 29 Jun 2023

Albumedix and Valneva expand collaboration to include newly approved inactivated COVID-19 vaccine

Albumedix Ltd., a recognized global leader in Recombinant Human Albumin (rHA), specializing in the enablement of advanced therapies and biopharmaceuticals, today announces the expansion of its existing collaboration with Valneva SE, a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need.

From Albumedix Ltd. 29 Jun 2023

Researcher from Wageningen University wins Green CellDrop Giveaway

DeNovix Inc. is pleased to announce the winner of the Green CellDrop Automated Cell Counter Giveaway: Michiel Schrijen from Wageningen University, Netherlands! Selected at random from thousands of entries from scientists worldwide, the CellDrop will be housed in the Biosystematics Group at the university.

From DeNovix Inc. 29 Jun 2023

Pandemic paralysis: COVID-19 halts neglected tropical disease campaigns, study reveals solutions

In a recent study published in the journal PLoS Neglected Tropical Diseases, researchers evaluated the impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic on mass drug administration (MDA) programming. They also provided solutions by neglected tropical disease (NTD) stakeholders for the relaunch of MDA implementation activities.

28 Jun 2023

Cambridge psychologists develop new test to measure a person’s susceptibility to misinformation

University of Cambridge psychologists have developed the first validated "misinformation susceptibility test": a quick two-minute quiz that gives a solid indication of how vulnerable a person is to being duped by the kind of fabricated news that floods online spaces.

28 Jun 2023

CognoSpeak: AI tool uses speech technology to quickly assess dementia risk

A new AI tool that could help doctors assess the early signs of dementia and Alzheimer's more quickly and efficiently, has been developed by researchers at the University of Sheffield.

28 Jun 2023

Vitamin D supplements may reduce risk of heart attacks in older adults

Vitamin D supplements may reduce the risk of major cardiovascular events such as heart attacks among people aged over 60, finds a clinical trial published by The BMJ today.

28 Jun 2023

Trial shows no benefit of prescribing an opioid for people with acute back or neck pain

Opioid pain-relieving medicines are not more effective than a placebo in relieving acute back and neck pain and may even cause harm, according to a world-first trial led by the University of Sydney.

28 Jun 2023

Increasing numbers of doctors in England and Wales are opting to take voluntary early retirement

Increasing numbers of doctors are opting to take voluntary early retirement, rather than waiting to claim their pension at retirement age, official figures show.

28 Jun 2023

Use of menopausal hormone therapy associated with increased rate of dementia and Alzheimer's

Use of menopausal hormone therapy is associated with an increased rate of dementia and Alzheimer's disease, suggests a large Danish study published by The BMJ today.

28 Jun 2023

Elucidating the role of the gut-brain-axis in autism

The study investigates the relationship between the gut and the brain in autism spectrum disorder (ASD), identifying microbial profiles and metabolic products associated with ASD phenotypes, dietary patterns, and inflammation. The findings provide insights into the role of the gut-brain axis in ASD and its potential impact on understanding and managing the disorder.

28 Jun 2023

New drug effective as a treatment against ulcerative colitis, clinical trial shows

A new drug, investigated by Amsterdam UMC together with colleagues around the world, is effective as a treatment against ulcerative colitis.

28 Jun 2023

Medical News

The protective effects of extra virgin olive oil on disease risk factors

Tirzepatide triumphs in significant weight reduction for people with type 2 diabetes

Researchers screen 16 UK native bat species for coronaviruses with zoonotic potential

The Lancet study unveils exciting findings on retatrutide as a novel treatment for type 2 diabetes

From deserts to desserts: cacti components for new functional foods

Study reveals oral Semaglutide 50 mg as promising treatment for obesity in adults: the Lancet report

Study suggests blood group A may directly influence SARS-CoV-2 infectious risk

Understanding the biological effects of SARS-CoV-2 persistence in children

Albumedix enters into collaboration agreement with Cell and Gene Therapy Catapult

Albumedix and Valneva expand collaboration to include newly approved inactivated COVID-19 vaccine

Researcher from Wageningen University wins Green CellDrop Giveaway

Pandemic paralysis: COVID-19 halts neglected tropical disease campaigns, study reveals solutions

Cambridge psychologists develop new test to measure a person’s susceptibility to misinformation

CognoSpeak: AI tool uses speech technology to quickly assess dementia risk

Vitamin D supplements may reduce risk of heart attacks in older adults

Trial shows no benefit of prescribing an opioid for people with acute back or neck pain

Increasing numbers of doctors in England and Wales are opting to take voluntary early retirement

Use of menopausal hormone therapy associated with increased rate of dementia and Alzheimer's

Elucidating the role of the gut-brain-axis in autism

New drug effective as a treatment against ulcerative colitis, clinical trial shows

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Latest News